아시아 태평양 지역 항암화학요법 가운 및 장갑 시장 규모 및 2035년까지의 전망

APAC Chemotherapy Gowns and Gloves Market Size and Forecast till 2035

상품코드MRFRHC300018WCR
발행기관Market Research Future
발행일2025.10.19
페이지 수174 Pages
포맷PDF
커버리지Asia Pacific

₩4,425,000 – ₩7,875,000

보고서 요약(국문)

아시아 태평양 지역의 항암 치료 가운 및 장갑 시장은 2035년까지 25억 3,110만 달러에 도달할 것으로 예상되며, 2035년 말까지 연평균 6.2%의 성장률을 보일 것으로 전망됩니다. 항암 치료 가운과 장갑은 개인 보호 장비(PPE)의 핵심 구성 요소 중 하나로, 폴리에틸렌 코팅 폴리프로필렌, 폴리우레탄, 니트릴 등 높은 차단성과 내화학성을 갖춘 소재로 제작됩니다. 의료진을 세포독성 약물로부터 보호하는 데 필수적인 이 제품들은 가운은 얼굴 전체를 덮는 보호 장비이며, ASTM D6978 규격에 따라 테스트된 장갑은 다양한 종양학 환경에서 안전성, 오염 방지 및 규정 준수를 보장하는 이중 장갑 착용에 사용됩니다.

시장 성장 촉진 요인
전 세계 암 환자의 약 58%를 차지하는 아시아 태평양 지역의 높은 암 발병률은 항암 치료 가운 및 장갑 수요에 가장 큰 영향을 미치는 요인으로 작용하고 있습니다. 중국, 인도, 일본과 같은 주요 국가에서 항암 치료 건수가 증가함에 따라, 치료 과정에서 발생하는 독성 물질 노출로부터 의료진을 보호하기 위해 보호복을 지속적으로 착용해야 할 필요성이 더욱 커지고 있습니다. 종양학 분야가 성장하고 안전 기준이 더욱 엄격해짐에 따라, 지속적으로 필요한 개인보호장비(PPE)에 대한 수요도 꾸준히 증가하고 있습니다.

부문 개요
제품 유형

• 항암 치료 가운
o AAMI 레벨 2: 저위험 작업에 필요한 기본적인 체액 보호 기능

o AAMI 레벨 3: 일반적인 항암제 취급에 필요한 중간 수준의 차단 기능

o AAMI 레벨 4: 유해 약물 노출에 대한 최고 수준의 보호 기능

o 격리 가운: 보조 항암 치료 시술에 필요한 일반적인 보호 기능

• 항암 치료 장갑: 약물 저항성 장갑으로 안전한 취급 보장

재질

• 가운
o 부직포: 오염 방지를 위한 가볍고 일회용 소재

o 직조 원단: 구조적 내구성을 제공하는 재사용 가능한 가운

• 코팅 원단: 고강도 작업에 적합한 향상된 내화학성

• 장갑

o 니트릴 고무: 강력한 내화학성과 뚫림 방지 기능
o 네오프렌: 안정적인 차단 성능을 갖춘 유연한 장갑 소재
o 폴리이소프렌: 라텍스와 유사한 편안함과 항암제 내성

최종 사용처

• 병원: 항암 치료용 개인보호장비(PPE) 소비량이 많은 곳

• 암 전문 치료 센터: 엄격한 보호가 필요한 특정 종양 치료 병동

• 조제 약국: 최고의 안전이 요구되는 중요한 약물 조제 구역

판매 채널

• 온라인 판매: 디지털 플랫폼을 통한 편리한 구매

• 오프라인 판매: 병원 및 유통업체를 기반으로 한 전통적인 공급 방식

연구 전망
아시아 태평양 지역의 항암 치료 가운 및 장갑 시장은 빠르게 성장하고 있으며, 이러한 성장의 주요 요인은 암 발병률 증가, 종양 치료 인프라 확충, 그리고 인증된 내화학성 PPE에 대한 소비자들의 선호도 증가입니다. 일부 공공 시스템 도입을 제한하는 비용 부담에도 불구하고, 강화된 규제 감독과 지역 제조업 성장으로 인해 시장은 고품질의 규정 준수 제품으로 향하는 추세를 보이고 있습니다.

시장 성장 동력을 형성하는 전략적 동인
이러한 동인 중 하나는 암 발병 건수 증가입니다. 이는 의료비 지출 증가와 산업 안전 프로토콜의 엄격성 강화로 직결되며, 결과적으로 아시아 태평양 지역에서 항암 치료용 특수 가운과 장갑에 대한 수요가 급증하고 있습니다. 종양학 시술 건수 증가와 세포독성 물질 노출 위험에 대한 인식 제고로 인해 병원에서는 의료진 보호를 위해 인증된 개인보호장비(PPE)를 우선시하고 있습니다. 이러한 변화는 공공 및 민간 의료 부문 모두에서 고품질의 규정 준수 제품 보급을 강화하고 있습니다.

주요 보고서 특징
• 시장 규모 2024: 13억 2,170만 달러

• 시장 규모 2035: 25억 3,110만 달러

• 연평균 성장률(2025-2035): 6.2%

• 기준 연도: 2025년

• 시장 예측 기간: 2025-2035년

시장 세분화별 성장

• 제품 유형: 항암 치료 가운 - 5.6%, 항암 치료 장갑 - 6.3%

• 소재: 가운 - 5.6%, 장갑 - 6.3%

• 최종 사용자: 병원 - 6.4%, 암 전문 치료 센터 - 6.0%

• 판매 채널: 온라인 판매 - 6.4%, 오프라인 판매 - 6.1%

보고서 요약(영어 원문)

The APAC chemotherapy gowns and gloves market is projected to reach USD 2,531.1 million by 2035, growing at a CAGR of 6.2% by the end of 2035. Chemotherapy gowns and gloves are one of the most essential parts of PPE and are made from materials that have high-barrier and are resistant to chemicals, including polyethylene-coated polypropylene, polyurethane, and nitrile. To protect healthcare workers from exposure to cytotoxic drugs. The gowns are full coverage protective pieces, while gloves tested by ASTM D6978 are used for double-gloving practices that ensure safety, contamination control, and compliance in the different oncology settings.

Market Growth Catalysts
The cancer burden in the Asia Pacific region, which is the source of almost 58% of the worldwide cancer cases, continues to be the most significant factor affecting the demand for chemotherapy gowns and gloves. The higher the number of treatments in the major countries such as China, India, and Japan, the more it will be necessary to use protective clothing continuously in order to protect healthcare workers from the toxic exposure that comes with the treatment. As the oncology sector grows and safety standards become stricter, the demand for PPE, which is a recurring need, has been going up continuously.

Segment Overview
Product Type
• Chemotherapy Gowns
o AAMI Level 2: Basic fluid protection for low-risk tasks.
o AAMI Level 3: Moderate barrier for routine chemotherapy handling.
o AAMI Level 4: Highest protection against hazardous drug exposure.
o Isolation Gowns: General coverage for supportive oncology procedures.
• Chemotherapy Gloves: Drug-resistant gloves ensuring safe handling.
Material
• Gowns
o Non-Woven Fabrics: Lightweight, disposable material for contamination control.
o Woven Fabrics: Reusable gowns offering structured durability.
o Coated Fabric: Enhanced chemical resistance for intensive tasks.
• Gloves
o Nitrile Rubber: Strong chemical resistance and puncture protection.
o Neoprene: Flexible glove material with stable barrier performance.
o Polyisoprene: Latex-like comfort with chemotherapy resistance.
End-Use
• Hospitals: High-volume chemotherapy PPE consumption points.
• Specialty Cancer Treatment Centers: Targeted oncology units needing strict protection.
• Compounding Pharmacies: Critical drug-mixing areas requiring maximum safety.
Sales Channel
• Online Sales: Convenient procurement through digital platforms.
• Offline Sales: Traditional hospital and distributor-based sourcing.

Research Perspectives
The Asia Pacific market for chemotherapy gowns and gloves is rapidly growing, and the major factors contributing to this growth are the rising cancer incidence, the growing oncology infrastructure, and the inclination of most people toward certified, chemical-resistant PPE. Despite pressure due to costs that limit the adoption of some public systems, the market is still moving towards high-quality and compliant products because of increased regulatory scrutiny and regional manufacturing growth.

Strategic Drivers Shaping Market Momentum
One of such factors is the rise in the number of cancer cases, which directly implicates the expansion of health care expenditure as well as the strictness of the occupational safety protocols, which in turn leads to the demand for specialized gowns and gloves for chemotherapy treatment to rise drastically in the Asia Pacific region. As more oncology procedures are carried out and more people become aware of the risks linked with cytotoxic exposures, hospitals are prioritizing certified PPE for worker protection. The shift is thus reinforcing the penetration of high-quality compliant products in both public and private healthcare sectors.

Key Report Attributes
• Market Size 2024: USD 1,321.7 Million
• Market Size 2035: USD 2,531.1 Million
• CAGR (2025-2035): 6.2%
• Base Year: 2025
• Market Forecast Period: 2025-2035

Market Segmentation Growth
• Product Type: Chemotherapy Gowns - 5.6%, Chemotherapy Gloves - 6.3%.
• Material: Gowns - 5.6%, Gloves - 6.3%.
• End-Use: Hospitals - 6.4%, Specialty Cancer Treatment Centers - 6.0%.
• Sales Channel: Online Sales - 6.4%, Offline Sales - 6.1%.

상세 목차

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ........ 21
2 MARKET INTRODUCTION ......... 23
2.1 DEFINITION ....... 23
2.2 SCOPE OF THE STUDY ....... 23
2.3 RESEARCH OBJECTIVE ..... 23
2.4 MARKET STRUCTURE ....... 24
3 RESEARCH METHODOLOGY ......... 25
3.1 OVERVIEW ......... 25
3.2 DATA FLOW ....... 27
3.2.1 DATA MINING PROCESS ..... 27
3.3 PURCHASED DATABASE: ....... 28
3.4 SECONDARY SOURCES: ..... 29
3.4.1 SECONDARY RESEARCH DATA FLOW: ......... 30
3.5 PRIMARY RESEARCH: ........ 31
3.5.1 PRIMARY RESEARCH DATA FLOW: ......... 32
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ......... 33
3.5.3 PRIMARY RESEARCH: COUNTRYAL COVERAGE ........ 33
3.6 APPROACHES FOR MARKET END USER ESTIMATION: ......... 34
3.6.1 REVENUE ANALYSIS APPROACH ......... 34
3.6.2 DATA FORECASTING ...... 35
3.6.3 DATA FORECASTING TECHNIQUE ......... 35
3.7 DATA MODELING ....... 36
3.7.1 MICROECONOMIC FACTOR ANALYSIS: ......... 36
3.7.2 DATA MODELING: ........ 37
4 MARKET DYNAMICS ........ 39
4.1 INTRODUCTION ..... 39
4.2 DRIVERS ......... 41
4.2.1 INCREASING CANCER INCIDENCE ........ 41
4.2.2 GROWING AWARENESS OF CHEMOTHERAPY SAFETY ......... 41
4.2.3 ADVANCEMENTS IN HEALTHCARE INFRASTRUCTURE ...... 42
4.2.4 GOVERNMENT SUPPORT AND INITIATIVES ........ 42
4.2.5 RISING DEMAND FOR PROTECTIVE MEDICAL GEAR ....... 43
4.3 RESTRAINTS ..... 44
4.3.1 HIGH COST OF CHEMOTHERAPY PRODUCTS ..... 44
4.3.2 LIMITED PREDICTIVE ACCURACY FOR COMPLEX TOXICITY ENDPOINTS ....... 45
4.3.3 REGULATORY CHALLENGES AND COMPLIANCE ISSUES ....... 45
4.3.4 LIMITED AWARENESS AND EDUCATION AMONG HEALTHCARE PROVIDERS ...... 46
4.3.5 COMPETITION FROM ALTERNATIVE CANCER TREATMENT SOLUTIONS ..... 46
4.4 OPPORTUNITY ....... 48
4.4.1 DEVELOPMENT OF SUSTAINABLE AND ECO-FRIENDLY MATERIALS ......... 48
4.4.2 EXPANSION OF E-COMMERCE CHANNELS FOR MEDICAL SUPPLIES ...... 48
5 MARKET FACTOR ANALYSIS ......... 50
5.1 SUPPLY CHAIN ANALYSIS ........ 50
5.1.1 RAW MATERIAL SOURCING AND PROCUREMENT ...... 50
5.1.2 MANUFACTURING AND QUALITY ASSURANCE..... 50
5.1.3 REGULATORY COMPLIANCE AND CERTIFICATION ..... 50
5.1.4 DISTRIBUTION AND LOGISTICS MANAGEMENT ....... 51
5.1.5 END-USER DEMAND AND INVENTORY MANAGEMENT ........ 51
5.1.6 SUPPLY CHAIN RESILIENCE AND RISK MITIGATION ...... 51
5.2 PORTER’S FIVE FORCES MODEL ........ 52
5.2.1 THREAT OF NEW ENTRANTS (LOW) ....... 52
5.2.2 BARGAINING POWER OF SUPPLIERS (MODERATE TO HIGH) ....... 53
5.2.3 THREAT OF SUBSTITUTES (LOW) ..... 53
5.2.4 BARGAINING POWER OF BUYERS (HIGH) ......... 53
5.2.5 INTENSITY OF RIVALRY (HIGH) ........ 54
5.3 APAC CHEMOTHERAPY SPILL KIT VOLUME ANALYSIS, 2019 – 2035 (THOUSAND UNITS)...... 54
5.4 APAC CHEMOTHERAPY MAKESHIFT SPILL KIT USAGE ANALYSIS ......... 55
5.4.1 TYPICAL KIT CONTENTS (CLINICAL MINIMUM) — HOSPITAL ASSEMBLED ......... 55
5.4.2 COMPONENT PRICE RANGES AND HOSPITAL-ASSEMBLED KIT COST CALCULATION ......... 56
5.4.2.1 ASSEMBLED SMALL IN-HOUSE KIT — LOW VS HIGH SPEC ...... 56
5.5 APAC CHEMOTHERAPY GLOVES – USAGE OF LATEX ...... 57
6 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE ...... 60
6.1 INTRODUCTION ..... 60
6.1.1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET SIZE: MARKET ESTIMATES AND FORECAST,
BY PRODUCT TYPE, 2019 – 2035 ......... 60
6.2 CHEMOTHERAPY GOWNS..... 61
6.3 CHEMOTHERAPY GLOVES ......... 62
7 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL ...... 63
7.1 INTRODUCTION ..... 63
7.1.1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET SIZE: MARKET ESTIMATES AND FORECAST,
BY MATERIALS, 2019 – 2035 ..... 63
7.2 GLOVES ..... 65
7.3 GOWNS ...... 65
8 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USER ..... 66
8.1 INTRODUCTION ..... 66
8.1.1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET SIZE: MARKET ESTIMATES AND FORECAST,
BY END-USER, 2019 – 2035 ..... 66
8.2 HOSPITALS ........ 67
8.3 SPECIALTY CANCER TREATMENT CENTERS ....... 68
8.4 COMPOUNDING PHARMACIES ...... 68
9 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL ......... 70
9.1 INTRODUCTION ..... 70
9.1.1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET SIZE: MARKET ESTIMATES AND FORECAST,
BY SALES CHANNEL, 2019 – 2035 ....... 70
9.2 ONLINE ...... 71
9.3 OFFLINE ......... 72
10 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY COUNTRY ...... 73
10.1 INTRODUCTION ..... 73
10.2 NEW ZEALAND ...... 74
10.2.1 MARKET SHARE ANALYSIS – GLOVES ........ 74
10.2.2 MARKET SHARE ANALYSIS – GOWNS ........ 74
10.2.3 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY PRODUCT TYPE, 2019 – 2035 ......... 75
10.2.4 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY MATERIAL, 2019 – 2035 ...... 75
10.2.5 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY END-USER, 2019 – 2035 ..... 76
10.2.6 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY SALES CHANNEL, 2019 – 2035 ....... 77
10.3 INDIA ..... 77
10.3.1 MARKET SHARE ANALYSIS – GLOVES ........ 77
10.3.2 MARKET SHARE ANALYSIS – GOWNS ........ 78
10.3.3 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE, 2019 – 2035 .... 78
10.3.4 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035 ...... 79
10.3.5 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035 ..... 80
10.3.6 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL, 2019 – 2035 .. 80
10.4 JAPAN ....... 81
10.4.1 MARKET SHARE ANALYSIS – GLOVES ........ 81
10.4.2 MARKET SHARE ANALYSIS – GOWNS ........ 81
10.4.3 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE, 2019 – 2035 .. 82
10.4.4 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035 ......... 82
10.4.5 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035 ........ 83
10.4.6 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL, 2019 – 2035 84
10.5 SOUTH KOREA ....... 84
10.5.1 MARKET SHARE ANALYSIS – GLOVES ........ 84
10.5.2 MARKET SHARE ANALYSIS – GOWNS ........ 85
10.5.3 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY PRODUCT TYPE, 2019 – 2035 ......... 85
10.5.4 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY MATERIAL, 2019 – 2035 ...... 86
10.5.5 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY END-USER, 2019 – 2035 ..... 87
10.5.6 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY SALES CHANNEL, 2019 – 2035 ....... 87
10.6 MALAYSIA ......... 89
10.6.1 MARKET SHARE ANALYSIS – GLOVES ........ 89
10.6.2 MARKET SHARE ANALYSIS – GOWNS ........ 89
10.6.3 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY PRODUCT TYPE, 2019 – 2035 ......... 90
10.6.4 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035 ... 90
10.6.5 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035 .. 91
10.6.6 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY SALES CHANNEL, 2019 – 2035 ....... 92
10.7 AUSTRALIA ....... 92
10.7.1 MARKET SHARE ANALYSIS – GLOVES ........ 92
10.7.2 MARKET SHARE ANALYSIS – GOWNS ........ 93
10.7.3 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY PRODUCT TYPE, 2019 – 2035 ......... 93
10.7.4 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035 .. 94
10.7.5 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035 . 95
10.7.6 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL, 2019 – 2035 ....... 95
10.8 HONG KONG ....... 96
10.8.1 MARKET SHARE ANALYSIS – GLOVES ........ 96
10.8.2 MARKET SHARE ANALYSIS – GOWNS ........ 96
10.8.3 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE, 2019 – 2035 ......... 97
10.8.4 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035 97
10.8.5 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035 98
10.8.6 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL, 2019 – 2035 ....... 99
10.9 SINGAPORE ........ 99
10.9.1 MARKET SHARE ANALYSIS – GLOVES ........ 99
10.9.2 MARKET SHARE ANALYSIS – GOWNS ........ 100
10.9.3 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE, 2019 – 2035 ......... 100
10.9.4 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035 . 101
10.9.5 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035 . 102
10.9.6 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL, 2019 – 2035 ....... 102
10.10 REST OF APAC ....... 103
10.10.1 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE, 2019 – 2035 ......... 103
10.10.2 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY MATERIAL, 2019 – 2035 ...... 104
10.10.3 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY END-USER, 2019 – 2035 ..... 104
10.10.4 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST,
BY SALES CHANNEL, 2019 – 2035 ....... 105
11 COMPETITIVE LANDSCAPE ...... 106
11.1 INTRODUCTION ..... 106
11.2 MARKET SHARE ANALYSIS, 2024 ......... 106
11.3 COMPETITOR DASHBOARD........ 107
11.4 KEY DEVELOPMENTS & GROWTH STRATEGIES ....... 108
12 COMPANY PROFILES ...... 109
12.1 ANSELL ..... 109
12.1.1 COMPANY OVERVIEW ........ 109
12.1.2 FINANCIAL OVERVIEW ........ 110
12.1.3 PRODUCTS OFFERED ......... 111
12.1.4 SWOT ANALYSIS ..... 111
12.1.5 KEY STRATEGY ....... 112
12.2 CAREON ......... 113
12.2.1 COMPANY OVERVIEW ........ 113
12.2.2 FINANCIAL OVERVIEW ........ 114
12.2.3 PRODUCTS OFFERED ......... 114
12.2.4 SWOT ANALYSIS ..... 114
12.2.5 KEY STRATEGY ....... 115
12.3 CARDINAL HEALTH....... 116
12.3.1 COMPANY OVERVIEW ........ 116
12.3.2 FINANCIAL OVERVIEW ........ 117
12.3.3 PRODUCT OFFERED ...... 117
12.3.4 SWOT ANALYSIS ..... 118
12.3.5 KEY STRATEGY ....... 119
12.4 OWENS & MINOR, INC. (HALYARD) ........ 120
12.4.1 COMPANY OVERVIEW ........ 120
12.4.2 FINANCIAL OVERVIEW ........ 121
12.4.3 PRODUCTS OFFERED ......... 122
12.4.4 SWOT ANALYSIS ..... 123
12.4.5 KEY STRATEGY ....... 123
12.5 HARTALEGA...... 124
12.5.1 COMPANY OVERVIEW ........ 124
12.5.2 FINANCIAL OVERVIEW ........ 125
12.5.3 PRODUCT OFFERED ...... 125
12.5.4 SWOT ANALYSIS ..... 126
12.6 KANAM LATEX INDUSTRIES PVT. LTD ......... 127
12.6.1 COMPANY OVERVIEW ........ 127
12.6.2 PRODUCT OFFERED ...... 128
12.6.3 SWOT ANALYSIS ..... 128
12.6.4 KEY STRATEGY ....... 129
12.7 MEDICOM ...... 130
12.7.1 COMPANY OVERVIEW ........ 130
12.7.2 PRODUCT OFFERED ...... 131
12.7.3 SWOT ANALYSIS ..... 132
12.7.4 KEY STRATEGY ....... 132
12.8 MEDLINE INDUSTRIES ...... 133
12.8.1 COMPANY OVERVIEW ........ 133
12.8.2 PRODUCT OFFERED ..... 134
12.8.3 SWOT ANALYSIS ..... 134
12.8.4 KEY STRATEGY ....... 135
12.9 MUN APAC SDN BHD..... 136
12.9.1 COMPANY OVERVIEW ........ 136
12.9.2 PRODUCT OFFERED ..... 136
12.9.3 SWOT ANALYSIS ..... 137
12.10 MEDTECS ....... 138
12.10.1 COMPANY OVERVIEW ........ 138
12.10.2 FINANCIAL OVERVIEW ........ 139
12.10.3 PRODUCT OFFERED ..... 140
12.10.4 SWOT ANALYSIS ..... 140
12.10.5 KEY STRATEGY ....... 141
12.11 MULTIGATE ...... 142
12.11.1 COMPANY OVERVIEW ........ 142
12.11.2 PRODUCT OFFERED ..... 142
12.11.3 SWOT ANALYSIS ..... 143
12.12 OSAKI ......... 144
12.12.1 COMPANY OVERVIEW ........ 144
12.12.2 PRODUCT OFFERED ..... 145
12.12.3 SWOT ANALYSIS ..... 145
12.13 SARAYA ......... 146
12.13.1 COMPANY OVERVIEW ........ 146
12.13.2 PRODUCT OFFERED ..... 147
12.13.3 SWOT ANALYSIS ..... 147
12.14 SENTRY ..... 148
12.14.1 COMPANY OVERVIEW ........ 148
12.14.2 PRODUCT OFFERED ..... 148
12.14.3 SWOT ANALYSIS ..... 149
12.14.4 KEY STRATEGY ....... 149
12.15 TAKETORA ........ 150
12.15.1 COMPANY OVERVIEW ........ 150
12.15.2 PRODUCT OFFERED ..... 151
12.15.3 SWOT ANALYSIS ..... 151
12.16 TOP GLOVE ......... 152
12.16.1 COMPANY OVERVIEW ........ 152
12.16.2 FINANCIAL OVERVIEW ........ 153
12.16.3 PRODUCT OFFERED ..... 153
12.16.4 SWOT ANALYSIS ..... 154
12.16.5 KEY STRATEGY ....... 155
12.17 ULTRAHEALTH ..... 156
12.17.1 COMPANY OVERVIEW ........ 156
12.17.2 PRODUCT OFFERED ..... 157
12.17.3 SWOT ANALYSIS ..... 157
12.18 USL MEDICAL......... 158
12.18.1 COMPANY OVERVIEW ........ 158
12.18.2 PRODUCT OFFERED ..... 158
12.18.3 SWOT ANALYSIS ..... 159
12.19 INTERLAB LTD ...... 160
12.19.1 COMPANY OVERVIEW ........ 160
12.19.2 PRODUCT OFFERED ..... 160
12.19.3 SWOT ANALYSIS ..... 161
12.20 JACKSON ALLISON MEDICAL SUPPLIES ....... 162
12.20.1 COMPANY OVERVIEW ........ 162
12.20.2 PRODUCT OFFERED ..... 162
12.20.3 SWOT ANALYSIS ..... 163
12.21 SRI TRANG GLOVES ....... 164
12.21.1 COMPANY OVERVIEW ........ 164
12.21.2 FINANCIAL OVERVIEW ........ 165
12.21.3 PRODUCT OFFERED ..... 165
12.21.4 SWOT ANALYSIS ..... 166
12.22 BLOSSOM DISPOSABLES ........ 167
12.22.1 COMPANY OVERVIEW ........ 167
12.22.2 PRODUCT OFFERED ..... 167
12.22.3 SWOT ANALYSIS ..... 168
12.23 KOSSAN RUBBER INDUSTRIES BHD ...... 169
12.23.1 COMPANY OVERVIEW ........ 169
12.23.2 FINANCIAL OVERVIEW ........ 170
12.23.3 PRODUCT OFFERED ..... 170
12.23.4 SWOT ANALYSIS ..... 171
12.24 HUBEI KANGNING PROTECTIVE PRODUCTS CO., LTD ....... 172
12.24.1 COMPANY OVERVIEW ........ 172
12.24.2 PRODUCT OFFERED ..... 172
12.24.3 SWOT ANALYSIS ..... 173

언급된 주요 기업들

ANSELL LTD., Careon, Cardinal Health, Owens&Minor, Inc. (Halyard), Hartalega, Kanam Surgicare, Medicom, Medline, Medtecs

표 목록 (Tables)

LIST OF TABLES
TABLE 1 ASIA PACIFIC CHEMOTHERAPY SPILL KIT MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 54
TABLE 2 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 60
TABLE 3 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 60
TABLE 4 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 63
TABLE 5 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 64
TABLE 6 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 66
TABLE 7 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 66
TABLE 8 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 70
TABLE 9 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 70
TABLE 10 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 75
TABLE 11 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 75
TABLE 12 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 75
TABLE 13 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 76
TABLE 14 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 76
TABLE 15 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 76
TABLE 16 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 77
TABLE 17 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 77
TABLE 18 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 78
TABLE 19 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 79
TABLE 20 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 79
TABLE 21 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 79
TABLE 22 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 80
TABLE 23 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 80
TABLE 24 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 80
TABLE 25 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 80
TABLE 26 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 82
TABLE 27 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 82
TABLE 28 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 82
TABLE 29 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 83
TABLE 30 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 83
TABLE 31 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 83
TABLE 32 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 84
TABLE 33 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 84
TABLE 34 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 85
TABLE 35 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 86
TABLE 36 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 86
TABLE 37 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 86
TABLE 38 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 87
TABLE 39 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 87
TABLE 40 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 87
TABLE 41 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 87
TABLE 42 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 90
TABLE 43 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 90
TABLE 44 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 90
TABLE 45 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 91
TABLE 46 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 91
TABLE 47 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 91
TABLE 48 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 92
TABLE 49 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 92
TABLE 50 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 93
TABLE 51 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 94
TABLE 52 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 94
TABLE 53 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 94
TABLE 54 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 95
TABLE 55 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 95
TABLE 56 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 95
TABLE 57 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 95
TABLE 58 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 97
TABLE 59 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 97
TABLE 60 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 97
TABLE 61 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 98
TABLE 62 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 98
TABLE 63 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 98
TABLE 64 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 99
TABLE 65 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 99
TABLE 66 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 100
TABLE 67 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 101
TABLE 68 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 101
TABLE 69 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 101
TABLE 70 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 102
TABLE 71 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 102
TABLE 72 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 102
TABLE 73 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 102
TABLE 74 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 103
TABLE 75 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (THOUSAND UNITS) 103
TABLE 76 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 104
TABLE 77 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (THOUSAND UNITS) 104
TABLE 78 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 104
TABLE 79 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (THOUSAND UNITS) 105
TABLE 80 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 105
TABLE 81 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (THOUSAND UNITS) 105
TABLE 82 KEY DEVELOPMENT 108
TABLE 83 ANSELL: PRODUCT OFFERED 111
TABLE 84 CAREON: PRODUCT OFFERED 114
TABLE 85 CARDINAL HEALTH: PRODUCT OFFERED 117
TABLE 86 OWENS & MINOR, INC: PRODUCT OFFERED 122
TABLE 87 HARTALEGA: PRODUCT OFFERED 125
TABLE 88 KANAM LATEX INDUSTRIES PVT. LTD: PRODUCT OFFERED 128
TABLE 89 MEDICOM: PRODUCT OFFERED 131
TABLE 90 MEDLINE INDUSTRIES : PRODUCT OFFERED 134
TABLE 91 MUN APAC SDN BHD: PRODUCT OFFERED 136
TABLE 92 MEDTECS: PRODUCT OFFERED 140
TABLE 93 MULTIGATE: PRODUCT OFFERED 142
TABLE 94 OSAKI: PRODUCT OFFERED 145
TABLE 95 SARAYA: PRODUCT OFFERED 147
TABLE 96 SENTRY: PRODUCT OFFERED 148
TABLE 97 TAKETORA: PRODUCT OFFERED 151
TABLE 98 TOP GLOVE: PRODUCT OFFERED 153
TABLE 99 ULTRAHEALTH: PRODUCT OFFERED 157
TABLE 100 USL MEDICAL: PRODUCT OFFERED 158
TABLE 101 INTERLAB LTD: PRODUCT OFFERED 160
TABLE 102 JACKSON ALLISON MEDICAL SUPPLIES: PRODUCT OFFERED 162
TABLE 103 TOP GLOVE: PRODUCT OFFERED 165
TABLE 104 BLOSSOM DISPOSABLES : PRODUCT OFFERED 167
TABLE 105 KOSSAN RUBBER INDUSTRIES BHD: PRODUCT OFFERED 170
TABLE 106 HUBEI KANGNING PROTECTIVE PRODUCTS CO., LTD: PRODUCT OFFERED 172

그림 목록 (Figures)

LIST OF FIGURES

FIGURE 1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET: STRUCTURE 24
FIGURE 2 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET: GROWTH FACTOR ANALYSIS 40
FIGURE 3 DRIVER IMPACT ANALYSIS (2018-2035) 43
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2018-2035) 47
FIGURE 5 PORTER’S FIVE FORCES MODEL: ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET 52
FIGURE 6 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2024 (% SHARE) 61
FIGURE 7 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2024 (% SHARE) 64
FIGURE 8 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2024 (% SHARE) 67
FIGURE 9 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2024 (% SHARE) 71
FIGURE 10 NEW ZEALAND CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2024 74
FIGURE 11 NEW ZEALAND CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2024 74
FIGURE 12 INDIA CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2024 77
FIGURE 13 INDIA CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2024 78
FIGURE 14 JAPAN CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2024 81
FIGURE 15 JAPAN CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2024 81
FIGURE 16 SOUTH KOREA CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2024 84
FIGURE 17 SOUTH KOREA CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2024 85
FIGURE 18 MALAYSIA CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2024 89
FIGURE 19 MALAYSIA CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2024 89
FIGURE 20 AUSTRALIA CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2024 92
FIGURE 21 AUSTRALIA CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2024 93
FIGURE 22 HONG KONG CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2024 96
FIGURE 23 HONG KONG CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2024 96
FIGURE 24 SINGAPORE CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2024 99
FIGURE 25 SINGAPORE CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2024 100
FIGURE 26 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET: COMPETITIVE ANALSIS, 2024 106
FIGURE 27 COMPETITOR DASHBOARD: APAC SURGICAL GOWNS AND DRAPES MARKET 107
FIGURE 28 ANSELL: SWOT ANALYSIS 111
FIGURE 29 CAREON: SWOT ANALYSIS 114
FIGURE 30 CARDINAL HEALTH: SWOT ANALYSIS 118
FIGURE 31 OWENS & MINOR, INC : SWOT ANALYSIS 123
FIGURE 32 HARTALEGA: SWOT ANALYSIS 126
FIGURE 33 KANAM LATEX INDUSTRIES PVT. LTD: SWOT ANALYSIS 128
FIGURE 34 MEDICOM: SWOT ANALYSIS 132
FIGURE 35 MEDLINE INDUSTRIES : SWOT ANALYSIS 134
FIGURE 36 MUN APAC SDN BHD: SWOT ANALYSIS 137
FIGURE 37 MEDTECS: SWOT ANALYSIS 140
FIGURE 38 MULTIGATE: SWOT ANALYSIS 143
FIGURE 39 OSAKI: SWOT ANALYSIS 145
FIGURE 40 SARAYA: SWOT ANALYSIS 147
FIGURE 41 SENTRY: SWOT ANALYSIS 149
FIGURE 42 TAKETORA: SWOT ANALYSIS 151
FIGURE 43 TOP GLOVE: SWOT ANALYSIS 154
FIGURE 44 ULTRAHEALTH: SWOT ANALYSIS 157
FIGURE 45 USL MEDICAL: SWOT ANALYSIS 159
FIGURE 46 INTERLAB LTD: SWOT ANALYSIS 161
FIGURE 47 JACKSON ALLISON MEDICAL SUPPLIES: SWOT ANALYSIS 163
FIGURE 48 SRI TRANG GLOVES: SWOT ANALYSIS 166
FIGURE 49 BLOSSOM DISPOSABLES : SWOT ANALYSIS 168
FIGURE 50 KOSSAN RUBBER INDUSTRIES BHD: SWOT ANALYSIS 171
FIGURE 51 HUBEI KANGNING PROTECTIVE PRODUCTS CO., LTD: SWOT ANALYSIS 173